U.S. Markets closed

Vertex Pharmaceuticals to Target 90% of Cystic Fibrosis Patients

Margaret Patrick
Vertex Pharmaceuticals to Target 90% of Cystic Fibrosis Patients

Should Investors Be Interested in Vertex Pharmaceuticals in 2018?